Exalt Diagnostics is Other Commercial Products in United States that focus on enhanced fluorescence technology business. Founded in 2012. They cover business area such as photonic crystal, high sensitivity, highly portable biosensor detection instrumentation, care clinic, consumer, concentration, dozen, protein, an individual, fluorescent light emitter, dna, blood sample, doctor, disease, cancer, serious symptom.
2012
( 12 years old in 2024 )
Enhanced Fluorescence Technology
-
60 Hazelwood Drive
Champaign, IL 61820
United States
Private
photonic crystalhigh sensitivityhighly portable biosensor detection instrumentationcare clinicconsumerconcentrationdozenproteinan individualfluorescent light emitterdnablood sampledoctordiseasecancerserious symptom
* We use standard office opening hours in near Exalt Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Exalt Diagnostics is Other Commercial Products business from United States that founded in 2012 (12 years old in 2024), Exalt Diagnostics business is focusing on Enhanced Fluorescence Technology.
Exalt Diagnostics headquarter office and corporate office address is located in 60 Hazelwood Drive Champaign, IL 61820 United States.
Exalt Diagnostics was founded in United States.
In 2024, Exalt Diagnostics is currently focus on enhanced fluorescence technology sector.
Above is snippet of Google Trends for "enhanced fluorescence technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Exalt Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
